1. Home
  2. AMSC vs HROW Comparison

AMSC vs HROW Comparison

Compare AMSC & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Superconductor Corporation

AMSC

American Superconductor Corporation

HOLD

Current Price

$33.14

Market Cap

1.7B

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$46.41

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMSC
HROW
Founded
1987
1998
Country
United States
United States
Employees
400
373
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
AMSC
HROW
Price
$33.14
$46.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$52.00
$69.86
AVG Volume (30 Days)
824.0K
728.1K
Earning Date
05-20-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
1806.25
N/A
EPS
3.05
N/A
Revenue
$900,000.00
N/A
Revenue This Year
$34.98
$31.62
Revenue Next Year
$21.38
$50.77
P/E Ratio
$10.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.87
$28.54
52 Week High
$70.49
$54.98

Technical Indicators

Market Signals
Indicator
AMSC
HROW
Relative Strength Index (RSI) 34.52 65.60
Support Level $29.35 $44.30
Resistance Level $33.57 $54.73
Average True Range (ATR) 2.18 2.28
MACD -0.23 -0.03
Stochastic Oscillator 16.86 83.74

Price Performance

Historical Comparison
AMSC
HROW

About AMSC American Superconductor Corporation

American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: